Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sutro Biopharma (STRO) Assets Average (2018 - 2025)

Sutro Biopharma (STRO) has disclosed Assets Average for 8 consecutive years, with $191.7 million as the latest value for Q4 2025.

  • Quarterly Assets Average fell 54.29% to $191.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $191.7 million through Dec 2025, down 54.29% year-over-year, with the annual reading at $280.5 million for FY2025, 34.61% down from the prior year.
  • Assets Average hit $191.7 million in Q4 2025 for Sutro Biopharma, down from $236.0 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $470.4 million in Q3 2024 to a low of $191.7 million in Q4 2025.
  • Historically, Assets Average has averaged $373.1 million across 5 years, with a median of $379.4 million in 2021.
  • Biggest five-year swings in Assets Average: surged 142.6% in 2021 and later tumbled 54.29% in 2025.
  • Year by year, Assets Average stood at $356.4 million in 2021, then rose by 13.29% to $403.8 million in 2022, then grew by 11.74% to $451.2 million in 2023, then dropped by 7.03% to $419.5 million in 2024, then crashed by 54.29% to $191.7 million in 2025.
  • Business Quant data shows Assets Average for STRO at $191.7 million in Q4 2025, $236.0 million in Q3 2025, and $291.9 million in Q2 2025.